In gene therapy to treat adenosine deaminase deficiency disorder, which of the patients blood cells are used?

As a first step towards gene therapy, lymphocytes from the blood of the patient are grown in a culture outside the body. A functional ADA cDNA (using a retroviral vector) is then introduced into these lymphocytes, which are subsequently returned to the patient.